Interpace Biosciences, Inc.
General ticker "IDXG" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $5.4M (TTM average)
Interpace Biosciences, Inc. does not follow the US Stock Market performance with the rate: -4.2%.
Estimated limits based on current volatility of 3.4%: low 0.89$, high 0.95$
Factors to consider:
- Total employees count: 1620 as of 1998
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.63$, 2.00$]
- 2024-12-30 to 2025-12-30 estimated range: [0.71$, 2.18$]
Financial Metrics affecting the IDXG estimates:
- Positive: with PPE of -0.3 at the end of fiscal year the price was low
- Positive: -3.60 < Operating profit margin, % of 6.97
- Positive: Operating cash flow per share per price, % of 85.95 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -0.89 <= -0.15
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.87 > 6.04
- Negative: Shareholder equity ratio, % of -473.63 <= 18.93
- Positive: Inventory ratio change, % of -0.74 <= 0
Short-term IDXG quotes
Long-term IDXG plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $33.12MM | $31.84MM | $40.21MM |
| Operating Expenses | $39.45MM | $35.45MM | $37.41MM |
| Operating Income | $-6.34MM | $-3.62MM | $2.80MM |
| Non-Operating Income | $-1.41MM | $-2.22MM | $-1.68MM |
| Interest Expense | $0.50MM | $0.16MM | $0.90MM |
| R&D Expense | $1.49MM | $0.70MM | $0.64MM |
| Income(Loss) | $-7.74MM | $-5.84MM | $1.13MM |
| Taxes | $-0.70MM | $0.03MM | $0.02MM |
| Other Income(Loss) | $-7.91MM | $-16.09MM | $-0.31MM |
| Profit(Loss)* | $-14.75MM | $-5.87MM | $0.49MM |
| Stockholders Equity | $-42.42MM | $-63.07MM | $-61.67MM |
| Inventory | $1.79MM | $1.22MM | $1.23MM |
| Assets | $38.43MM | $15.98MM | $13.02MM |
| Operating Cash Flow | $-8.72MM | $-7.69MM | $3.79MM |
| Capital expenditure | $0.35MM | $0.32MM | $0.47MM |
| Investing Cash Flow | $-0.32MM | $6.21MM | $-0.09MM |
| Financing Cash Flow | $8.98MM | $3.00MM | $-5.03MM |
| Earnings Per Share** | $-3.57 | $-1.38 | $0.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.